Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

          - [OMB Number 1117-0029]

# AGENCY:

Drug Enforcement Administration, Department of Justice.

# ACTION:

60-Day notice.

# SUMMARY:

The Department of Justice, Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget for review and approval in accordance with the Paperwork Reduction Act of 1995.

# DATES:

Comments are encouraged and will be accepted for 60 days until July 5, 2022.

# FOR FURTHER INFORMATION CONTACT:

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776-2265.

# SUPPLEMENTARY INFORMATION:

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points:

—Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

—Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

—Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and

                    —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology,                     *e.g.,*                     permitting electronic submission of responses.                

## Overview of This Information Collection

                    1.                     *Type of Information Collection:*                     Extension of a currently approved collection.                

                    2.                     *Title of the Form/Collection:*                     Annual Reporting Requirement for Manufacturers of Listed Chemicals.                

                    3.                     *The agency form number, if any, and the applicable component of the Department sponsoring the collection:*                     Form number: N/A. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division.                

                    4.                     *Affected public who will be asked or required to respond, as well as a brief abstract:*

*Affected public (Primary):*                     Business or other for-profit.                

*Affected public (Other):*                     None.                

*Abstract:*                     Pursuant to 21 U.S.C. 830(b)(2) and 21 CFR 1310.05(d), manufacturers of listed chemicals must file annual reports of manufacturing, inventory, and use data for the listed chemicals they manufacture. These reports allow DEA to monitor the volume and availability of domestically manufactured listed chemicals, which may be subject to diversion for the illicit production of controlled substances.                

                    5.                     *An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:*                     Each respondent for this information collection completes one response per year. DEA estimates there are 50 respondents, and that each response takes 0.25 hours to complete.                

                    6.                     *An estimate of the total public burden (in hours) associated with the proposed collection:*                     DEA estimates this collection takes a total of 12.5 annual burden hours.                

If additional information is required, please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530.

Dated: May 3, 2022.

Melody Braswell,

Department Clearance Officer for PRA, U.S. Department of Justice.

[FR Doc. 2022-09804 Filed 5-5-22; 8:45 am]

BILLING CODE 4410-09-P